Nutex Health Inc.
NUTX
$187.60
$1.760.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.65% | 42.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.65% | 42.73% | |||
| Cost of Revenue | -46.21% | 27.07% | |||
| Gross Profit | 50.78% | 68.13% | |||
| SG&A Expenses | 86.92% | 110.98% | |||
| Depreciation & Amortization | -3.19% | 5.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -34.16% | 3,495.32% | |||
| Operating Income | 49.78% | -45.06% | |||
| Income Before Tax | 52.93% | 195.67% | |||
| Income Tax Expenses | 50.53% | 48.58% | |||
| Earnings from Continuing Operations | 53.46% | 277.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -90.99% | -234.23% | |||
| Net Income | 40.67% | 295.53% | |||
| EBIT | 49.78% | -45.06% | |||
| EBITDA | 46.43% | -43.33% | |||
| EPS Basic | 43.10% | 300.12% | |||
| Normalized Basic EPS | 36.21% | -61.83% | |||
| EPS Diluted | 43.87% | 316.67% | |||
| Normalized Diluted EPS | 36.90% | -62.84% | |||
| Average Basic Shares Outstanding | -1.70% | -1.15% | |||
| Average Diluted Shares Outstanding | -2.20% | 1.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||